8 research outputs found

    “Do We Really Need Hepatitis B on the Second Day of Life?” Vaccination Mandates and Shifting Representations of Hepatitis B

    Get PDF
    In the decade following hepatitis B vaccine’s 1981 approval, U.S. health officials issued evolving guidelines on who should receive the vaccine: first, gay men, injection drug users, and healthcare workers; later, hepatitis B-positive women’s children; and later still, all newborns. States laws that mandated the vaccine for all children were quietly accepted in the 1990s; in the 2000s, however, popular anti-vaccine sentiment targeted the shot as an emblem of immunization policy excesses. Shifting attitudes toward the vaccine in this period were informed by hepatitis B’s changing popular image, legible in textual and visual representations of the infection from the 1980s through the 1990s. Notably, the outbreak of AIDS, the advent of genetically engineered pharmaceuticals, and a Democratic push for health reform shaped and reshaped hepatitis B’s public image. Hepatitis B thus became, in turn, an AIDS-like scourge; proof of a new era of pharmaceuticals; a threat from which all American children had a right to be protected; and a cancer-causing infection spread by teenage lifestyles. The metamorphosis of the infection’s image was reflected in evolving policy recommendations regarding who should receive the vaccine in the 1980s, and was key to securing broad uptake of the vaccine in the 1990s

    Toxic Knowledge: A Review of Baptized in PCBs

    No full text
    Elena Conis reviews Ellen Griffith Spears's Baptized in PCBs: Race, Pollution, and Justice in an All-American Town (Chapel Hill: University of North Carolina Press, 2014)

    Vaccine Nation: America’s Changing Relationship With Immunization

    No full text

    Breakout Session 3 - Motherwork as Bodywork: The Problem of Invisible Laborers

    No full text
    Breakout Session 3 - Motherwork as Bodywork: The Problem of Invisible Laborers Jessica Martucci, Mississippi State University Mothering to the Degree: Breastfeeding, Labor and Love Elena Conis, Emory University Vaccination as Motherwork: Mothers and the 21st Century Vaccination Debates Deanna Day, Chemical Heritage Foundation Data-driven Science for Creating Tiny Miracles: The Unacknowledged and Unpaid Labor of Fertility Chartin

    Drugs, sex, money and power: An HPV vaccine case study

    No full text
    In this paper we compare the experiences of seven industrialized countries in considering approval and introduction of the world's first cervical cancer-preventing vaccine. Based on case studies, articles from public agencies, professional journals and newspapers we analyse the public debate about the vaccine, examine positions of stakeholder groups and their influence on the course and outcome of this policy process. The analysis shows that the countries considered here approved the vaccine and established related immunization programs exceptionally quickly even though there still exist many uncertainties as to the vaccine's long-term effectiveness, cost-effectiveness and safety. Some countries even bypassed established decision-making processes. The voice of special interest groups has been prominent in all countries, drawing on societal values and fears of the public. Even though positions differed among countries, all seven decided to publicly fund the vaccine, illustrating a widespread convergence of interests. It is important that decision-makers adhere to transparent and robust guidelines in making funding decisions in the future to avoid capture by vested interests and potentially negative effects on access and equity.Vaccination Human Papillomavirus Decision making Public health Pharmaceutical policy Public policy
    corecore